These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6821487)

  • 41. [Blood sugar control in diabetics with the insulin pump. Comparison with discontinuous injections].
    Sudre Y; Abadie JC; Marechaud R; Rossi F; Gouet D; Queron B
    Sem Hop; 1982 Sep; 58(32):1801-4. PubMed ID: 6291163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
    Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implantable infusion pump management of insulin resistant diabetes mellitus.
    Buchwald H; Chute EP; Goldenberg FJ; Hitchcock CR; Hoogwerf BJ; Barbosa JJ; Rupp WM; Rohde TD
    Ann Surg; 1985 Sep; 202(3):278-82. PubMed ID: 4037902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
    Olsson PO
    Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study between the subcutaneous continuous insulin infusion pump and optimized conventional treatment. Effects at 6 months].
    Goicolea Opacua I; Hernández Colau I; Vázquez García JA
    Rev Clin Esp; 1986 Jun; 179(1):3-7. PubMed ID: 3526432
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of severe diabetic ketoacidosis in children. A comparative study of two methods (author's transl)].
    Dieterlen P; Charlochet F; Desjeux JF; Lestradet H
    Ann Pediatr (Paris); 1981 Sep; 28(7):499-503. PubMed ID: 6792973
    [No Abstract]   [Full Text] [Related]  

  • 48. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients.
    Schiffrin A; Belmonte M
    Diabetes Care; 1981; 4(6):595-600. PubMed ID: 6751734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrapartum management of insulin-dependent diabetes mellitus (IDDM) gestants. A comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump (CSIIP).
    Feldberg D; Dicker D; Samuel N; Peleg D; Karp M; Goldman JA
    Acta Obstet Gynecol Scand; 1988; 67(4):333-8. PubMed ID: 3051881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
    Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
    Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.
    Peters AL; Henry RR; Thakkar P; Tong C; Alba M
    Diabetes Care; 2016 Apr; 39(4):532-8. PubMed ID: 26989182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ambulatory treatment of diabetes in children by continuous subcutaneous infusion of insulin using a portable pump].
    Bougnères PF; Landier F; Lemmel C; Golse B; Chaussain JL
    Arch Fr Pediatr; 1984 Jan; 41(1):27-33. PubMed ID: 6721650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Insulin portable pump vs. intensified conventional injections in diabetes].
    Gutman RA; Litwak LE; Fagin JA; Plantalech L; Steiner S
    Medicina (B Aires); 1985; 45(3):225-30. PubMed ID: 3915900
    [No Abstract]   [Full Text] [Related]  

  • 56. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.
    Pickup J; Mattock M; Kerry S
    BMJ; 2002 Mar; 324(7339):705. PubMed ID: 11909787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.
    Ponder SW; Skyler JS; Kruger DF; Matheson D; Brown BW
    Diabetes Educ; 2008; 34(2):327-33. PubMed ID: 18375782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
    Navascués I; Kerner W; Pfeiffer EF
    Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient-reported experience with Velosulin human insulin in continuous subcutaneous insulin infusion.
    Marcus A; Bode B; Drexler A; Etkind E; Koch MM; Liljenquist JE; McCulloch DK; Strowig SM; Tanenberg RJ
    Clin Ther; 1995; 17(2):204-13. PubMed ID: 7614521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.